Based on the presence of key breast cancer biomarkers and global gene expression analyses, breast cancers can be generally subdivided into five subtypes, Estrogen Receptor (ER)+ Luminal A, Luminal B, HER2-enriched, Basal-like and the more recently identified Claudin Low subtype[1,2]. This evidence concerns the gene ERBB2 and breast cancer.